Propiedad y actividad de insiders de Amarin Corporation plc (AMRN): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $13.84 |
| Capitalización | $286M |
| Bolsa | NASDAQ |
| País | IE |
Operaciones Recientes de Insiders
| Fecha | Insider | Tipo | Acciones | Valor |
|---|---|---|---|---|
| 2026-08-01 | Fishman Peter L. | M-Exempt | 313 | |
| 2026-08-01 | Fishman Peter L. | F-InKind | 155 | $2K |
| 2026-08-01 | Fishman Peter L. | A-Award | 313 | |
| 2026-07-01 | Fishman Peter L. | M-Exempt | 2,447 | |
| 2026-07-01 | Fishman Peter L. | F-InKind | 1,206 | $19K |
| 2026-07-01 | Fishman Peter L. | A-Award | 2,447 | |
| 2026-07-01 | Keenan David Paul | M-Exempt | 3,688 | |
| 2026-07-01 | Keenan David Paul | F-InKind | 1,926 | $31K |
| 2026-07-01 | Keenan David Paul | A-Award | 3,688 | |
| 2026-07-01 | Ketchum Steven B | M-Exempt | 3,688 |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $98.3M | $73.6M | $249.2M | $644.6M | $187.0M | $219.5M | $217.7M | $199.3M | $121.0M | $134.9M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | $314.0M | $234.7M | $91.7M | $121.4M | $173.2M | $167.9M |
| Cuentas por Cobrar | $20.0M | $45.3M | $66.5M | $116.4M | $154.6M | $163.7M | $131.0M | $133.6M | $122.3M | $126.8M |
| Inventario | $20.5M | $30.3M | $57.8M | $76.8M | $188.9M | $234.7M | $228.7M | $258.6M | $166.0M | $195.9M |
| Activos Corrientes | $146.3M | $153.3M | $378.0M | $855.0M | $879.2M | $878.7M | $689.1M | $725.0M | $595.4M | $649.9M |
| Inmovilizado Material | $78000 | $28000 | $63000 | $10.9M | $10.1M | $9.1M | $9.9M | $8.4M | $7.6M | $6.5M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $13.4M |
| Activos Intangibles | $8.8M | $8.1M | $7.5M | $15.3M | $13.8M | $23.5M | $21.8M | $19.3M | $16.4M | 0 |
| Activos Totales | $167.0M | $161.6M | $385.7M | $882.2M | $966.0M | $1.07B | $886.2M | $831.7M | $685.3M | $670.8M |
| Cuentas por Pagar | $6.1M | $25.2M | $37.6M | $50.0M | $105.9M | $114.9M | $64.6M | $52.8M | $40.4M | $45.4M |
| Deuda a Corto | $31.3M | $22.8M | $34.2M | $50.1M | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Corrientes | $76.2M | $108.5M | $157.3M | $242.2M | $307.4M | $370.7M | $259.5M | $259.3M | $179.9M | $194.5M |
| Deuda a Largo | $85.2M | $99.8M | $46.1M | 0 | 0 | 0 | 0 | 0 | 0 | $6.1M |
| Pasivos Totales | $176.1M | $226.7M | $233.4M | $273.9M | $338.5M | $401.0M | $290.8M | $279.6M | $199.2M | $211.5M |
| Reservas | -$1.20B | -$1.27B | -$1.39B | -$1.41B | -$1.43B | -$1.42B | -$1.53B | -$1.59B | -$1.67B | -$1.71B |
| Patrimonio Neto | -$9.1M | -$65.1M | $152.3M | $608.3M | $627.5M | $667.1M | $595.3M | $552.1M | $486.2M | $459.3M |
| Deuda Total | $116.5M | $122.7M | $80.3M | $59.6M | $9.2M | $8.6M | $10.0M | $8.7M | $7.7M | $12.2M |
| Deuda Neta | $18.2M | $49.0M | -$168.9M | -$585.0M | -$491.8M | -$445.6M | -$299.3M | -$311.9M | -$286.5M | -$290.6M |
| Capital Circulante | $70.1M | $44.7M | $220.7M | $612.8M | $571.8M | $508.0M | $429.6M | $465.7M | $415.4M | $455.4M |
Salud financiera
| Deuda / Patrimonio | 0.01 |
| Ratio corriente | 3.67 |
Rentabilidad
| Rentabilidad sobre capital | -5.99% |
| Rentabilidad sobre capital invertido | -7.25% |
| Rentabilidad sobre activos | -4.34% |
| Margen bruto | 41.58% |
| Margen operativo | -17.91% |
| Margen neto | -14.57% |
Empresas relacionadas: ACIU · ALT · ANRO · CLLS · DBVT · ENGN · KRRO
Explorar sector: Healthcare · Drug Manufacturers - General
Más secciones de AMRN: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones